Skip to main content
OpenTrials
Completed

NCT Number: NCT02134509

Smartphone Application for Smoking Cessation

The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Behavior Cigarette Smoking Tobacco Smoking Tobacco Use

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale University School of Medicine

New Haven, Connecticut, 06511, United States

About this study

In this randomized control trial, subjects will be randomly assigned to receive one of two treatments: (1) a standard smartphone application to support smokers working to become quit-free, or (2) the tested intervention, an app that trains behavioral strategies for smoking cessation. The primary endpoint of interest will be 1-week point prevalence abstinence at end of treatment, and at 3 and 6 months follow-up for individuals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Smoke 5+ cigarettes/day
  • < 3 months abstinence in the past year
  • Have a smartphone
  • Score greater than or equal to 8 of 10 on the Contemplation Ladder (Biener & Abrams, 1991)

Exclusion criteria

  • None

Treatment and study plan

Experimental App

Behavioral

It is comprised of twenty-two modules of 10-15 minutes each, designed to teach behavioral strategies for smoking cessation using psychoeducation-based audio and videos, animations to reinforce key concepts, and in vivo exercises. In addition, 5 bonus modules become available upon completion of earlier modules; these may be accessed for additional practices to bolster other modules

Active Comparator App

Behavioral

It is comprised of 6 prompts per day asking individuals about their experience, behavior, and smoking habits, for 22-days.

Primary outcomes

  1. Point prevalence abstinence at 6 months

    Time frame: 6 months after beginning treatment

    Subjects will be assessed for smoking abstinence at a 6-month follow-up.

Secondary outcomes

  1. Point prevalence abstinence at 3 months

    Time frame: 3 months after beginning treatment

    Subjects will be assessed for smoking abstinence at a 3-month follow-up.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • American Heart Association
  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
May 9, 2014
Registry last updated
Apr 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.